Research on the evaluation system for drug venture capital based on clinical valueWU Xia, YANG Ting-ting, SHAO Rong2281-2285
Research on incentive system of innovative drug R&D from the perspective of venture capitalWU Xia, SHAO Rong2286-2293
Overview of accelerated approval by US FDA and some reference points for ChinaZHAO Chen-yang, WANG Hong-hang, HUANG Yun-hong, YANG Huan, GAO Chen-yan2294-2302
Advances in oral delivery technology of drug cocrystalsFENG Yu-miao, LIU Mei, HUANG Bi-yao, YANG Mei-yan2303-2308
Research progress of cardiotoxicity induced by targeted cancer therapiesZHANG Yi-zhe, WANG Mei-ting, ZHAO Qi, XING Hong-yan, ZHOU Jie, QIAO Ying, WANG Xi-jie2309-2314
Embolism risk following systemic intravascular administration of mesenchymal stem cells in preclinical and clinical studiesWANG Yan, LI Hua, TANG Na-ping, WEI Li-ping, MA Jing2315-2320
Advances in research on the mechanism of IKKα and IKKβ signaling pathways in tumors and related drugsZHOU Yong-ming, HUANG Wei-qi, JIANG Gao-feng, NI Jian, YU Mei-xia2321-2330
Advances in research on anti-tuberculosis natural small moleculesWANG Ren-feng, AN Ting-ting, JIANG Chang-he, ZHOU Lei, YANG Zai-chang2331-2340
Research progress in drugs for prevention and treatment of inner ear diseasesWU Ai-xin, YE Rui-qin, WEN Lu, CHEN Gang2341-2350
Research progress of anlotinib-induced hypertensionZHANG Li, XING Ya-qun, JIANG Jie-mei, XIA Quan2351-2357